Draft National Toxicology Program Monograph on Immunotoxicity Associated With Exposure to Perfluorooctanoic Acid or Perfluorooctane Sulfonate; Availability of Document; Request for Comments; Notice of Meeting, 9867-9869 [2016-04102]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 30, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); Budget Presentations; Reports of
Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Rm. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 22, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04103 Filed 2–25–16; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
20:41 Feb 25, 2016
Jkt 238001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immune Mechanisms.
Date: March 4, 2016.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jian Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095D,
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurochemistry.
Date: March 7, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interventions to Prevent and Treat
Addictions.
Date: March 8, 2016.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Miriam Mintzer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–523–0646,
mintzermz@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
9867
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Molecular Imaging Probe Development.
Date: March 9, 2016.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda MD 20892,
(Telephone Conference Call).
Contact Person: David L. Williams, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5110,
MSC 7854, Bethesda, MD 20892, (301) 435–
1174, williamsdl2@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 22, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04104 Filed 2–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Draft National Toxicology Program
Monograph on Immunotoxicity
Associated With Exposure to
Perfluorooctanoic Acid or
Perfluorooctane Sulfonate; Availability
of Document; Request for Comments;
Notice of Meeting
The notice announces a
meeting to peer review the draft NTP
monograph on immunotoxicity
associated with exposure to
perfluorooctanoic acid (PFOA) or
perfluorooctane sulfonate (PFOS). The
Office of Health Assessment and
Translation, Division of the National
Toxicology Program (DNTP), National
Institute of Environmental Health
Sciences (NIEHS), prepared the draft
NTP monograph. The peer review
meeting is open to the public.
Registration is requested for both public
attendance and oral comment and
required to access the webcast.
Information about the meeting and
registration are available at https://
ntp.niehs.nih.gov/go/36639.
DATES: Meeting: July 19, 2016, 9:00 a.m.
to approximately 2:00 p.m. Eastern
Daylight Time (EDT).
Document Availability: The draft NTP
monograph should be available by June
SUMMARY:
E:\FR\FM\26FEN1.SGM
26FEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
9868
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices
7, 2016, at https://ntp.niehs.nih.gov/go/
36639.
Written Public Comment Submission:
Deadline is July 5, 2016.
Registration for Oral Comments:
Deadline is July 12, 2016.
Registration for Meeting and/or to
View Webcast: Deadline is July 19,
2016. Registration to view the meeting
via the webcast is required.
ADDRESSES: Meeting Location: Rodbell
Auditorium, Rall Building, NIEHS, 111
T.W. Alexander Drive, Research
Triangle Park, NC 27709.
Meeting Web page: The draft NTP
monograph, preliminary agenda,
registration, and other meeting materials
will be available at https://
ntp.niehs.nih.gov/go/36639.
Webcast: The URL for viewing
webcast will be provided to those who
register.
FOR FURTHER INFORMATION CONTACT: Dr.
Yun Xie, NTP Designated Federal
Official, Office of Liaison, Policy, and
Review, DNTP, NIEHS, P.O. Box 12233,
MD K2–03, Research Triangle Park, NC
27709. Phone: (919) 541–3436, Fax:
(301) 451–5455, Email: yun.xie@nih.gov.
Hand Delivery/Courier: 530 Davis Drive,
Room 2161, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background on PFOA and PFOS:
PFOA and PFOS are persistent
chemicals that are widely distributed in
the environment, in part because of high
stability and little to no expected
degradation in the environment. PFOA
and PFOS have been used extensively
over the last 50 years in commercial and
industrial applications, including food
packaging, lubricants, water-resistant
coatings, and fire-retarding foams.
Through voluntary agreements, the
primary manufacturer of PFOS phased
out production in 2002, and PFOS is no
longer manufactured in the United
States. Similar arrangements have been
made for PFOA, and eight companies
that manufacture PFOA committed to
eliminate emissions and product
content by 2015. Although emissions
have been dramatically reduced, the
persistence and bioaccumulation of both
PFOA and PFOS result in detectable
levels in the U.S. population and,
therefore, these chemicals are of
potential human health relevance.
Several recent publications from 2012–
2014 have linked PFOA and PFOS
exposure to functional immune changes
in humans, which are consistent with
evidence of PFOA- and PFOS-related
immunotoxicity in animal studies.
NTP has conducted a systematic
review of the evidence for an
association between exposure to PFOA
or PFOS and immunotoxicity or
VerDate Sep<11>2014
20:41 Feb 25, 2016
Jkt 238001
immune-related health effects. The NTP
evaluation concept for immunotoxicity
associated with exposure to PFOA or
PFOS was presented and discussed at
the NTP Board of Scientific Counselors
(BSC) meeting on December 10, 2014
(79 FR 62640). The NTP evaluation
concept, related presentation, and BSC
meeting minutes are available at
https://ntp.niehs.nih.gov/go/9741. The
protocol for conducting this systematic
review is available at https://
ntp.niehs.nih.gov/go/749926.
Meeting and Registration: The
meeting is open to the public with time
set aside for oral public comment.
Please note that this will be both an inperson and web-based meeting. The
chair of the peer review panel and NTP
staff will be at the meeting location at
NIEHS. The peer review panel members
will be attending the meeting via webbased video conferencing. Public
attendees are welcome to watch the
meeting via webcast or attend in person.
Attendance at NIEHS is limited only by
the space available.
Registration to attend the meeting inperson or to view the webcast is by July
19, 2016, at https://ntp.niehs.nih.gov/go/
36639. Registration is required to view
the webcast; the URL for the webcast
will be provided in the email
confirming registration. Visitor and
security information for those attending
in-person is available at https://
www.niehs.nih.gov/about/visiting/
index.cfm. Individuals with disabilities
who need accommodation to participate
in this event should contact Dr. Yun Xie
at phone: (919) 541–3436 or email:
yun.xie@nih.gov. TTY users should
contact the Federal TTY Relay Service
at (800) 877–8339. Requests should be
made at least five business days in
advance of the event.
The preliminary agenda and draft
NTP monograph should be posted on
the NTP Web site (https://
ntp.niehs.nih.gov/go/36639) by June 7,
2016. Additional information will be
posted when available or may be
requested in hardcopy, see FOR FURTHER
INFORMATION CONTACT. Following the
meeting, a report of the peer review will
be prepared and made available on the
NTP Web site. Individuals are
encouraged to access the meeting Web
page to stay abreast of the most current
information regarding the meeting.
Request for Comments: The NTP
invites written and oral public
comments on the draft NTP monograph.
The deadline for submission of written
comments is July 5, 2016, to enable
review by the peer review panel and
NTP staff prior to the meeting.
Registration to provide oral comments is
by July 12, 2016, at https://
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
ntp.niehs.nih.gov/go/36639. Public
comments and any other
correspondence on the draft NTP
monograph should be sent to the FOR
FURTHER INFORMATION CONTACT. Persons
submitting written comments should
include their name, affiliation, mailing
address, phone, email, and sponsoring
organization (if any) with the document.
Written comments received in response
to this notice will be posted on the NTP
Web site according to NTP’s guidelines
for public comments (https://
ntp.niehs.nih.gov/ntp/about_ntp/
guidelines_public_comments_508.pdf),
and the submitter will be identified by
name, affiliation, and/or sponsoring
organization if applicable.
Public comment at this meeting is
welcome, with time set aside for the
presentation of oral comments on the
draft NTP monograph. Guidance for oral
public comments is available at https://
ntp.niehs.nih.gov/ntp/about_ntp/
guidelines_public_comments_508.pdf.
In addition to in-person oral comments
at NIEHS, public comments can be
presented by teleconference line. There
will be 50 lines for this call; availability
is on a first-come, first-served basis. The
lines will be open from 9:00 a.m. until
approximately 2:00 p.m. EDT on July
19, 2016, although oral comments will
be received only during the formal
public comment periods indicated on
the preliminary agenda. The access
number for the teleconference line will
be provided to registrants by email prior
to the meeting. Each organization is
allowed one time slot. At least 7
minutes will be allotted to each time
slot, and if time permits, may be
extended to 10 minutes at the discretion
of the chair.
Persons wishing to make an oral
presentation are asked to register online
at https://ntp.niehs.nih.gov/go/36639 by
July 12, 2016, and indicate whether they
will present comments in-person or via
the teleconference line. If possible, oral
public commenters should send a copy
of their slides and/or statement or
talking points at that time. Written
statements can supplement and may
expand the oral presentation.
Registration for in-person oral
comments will also be available at the
meeting, although time allowed for
presentation by on-site registrants may
be less than that for registered speakers
and will be determined by the number
of speakers who register on-site.
Background Information on OHAT:
OHAT was established to serve as an
environmental health resource to the
public and regulatory and health
agencies (https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3094430). This office
conducts evaluations to assess the
E:\FR\FM\26FEN1.SGM
26FEN1
9869
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Notices
evidence that environmental chemicals,
physical substances, or mixtures
(collectively referred to as ‘‘substances’’)
cause adverse health effects and
provides opinions on whether these
substances may be of concern given
what is known about current human
exposure levels. OHAT also organizes
workshops or state-of-the-science
evaluations to address issues of
importance in environmental health
sciences. Information about OHAT is
found at https://ntp.niehs.nih.gov/go/
ohat.
Background Information on NTP Peer
Review Panels: NTP panels are
technical, scientific advisory bodies
established on an ‘‘as needed’’ basis to
provide independent scientific peer
review and advise the NTP on agents of
public health concern, new/revised
toxicological test methods, or other
issues. These panels help ensure
transparent, unbiased, and scientifically
rigorous input to the program for its use
in making credible decisions about
human hazard, setting research and
testing priorities, and providing
information to regulatory agencies about
alternative methods for toxicity
screening. The NTP welcomes
nominations of scientific experts for
upcoming panels. Scientists interested
in serving on an NTP panel should
provide current curriculum vitae to the
FOR FURTHER INFORMATION CONTACT. The
authority for NTP panels is provided by
42 U.S.C. 217a; section 222 of the Public
Health Service (PHS) Act, as amended.
The panel is governed by the Federal
Advisory Committee Act, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
Dated: February 22, 2016.
John R. Bucher,
Associate Director, NTP.
[FR Doc. 2016–04102 Filed 2–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: The National
Physician Survey of Precision
Medicine in Cancer Treatment (NCI)
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health, has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on November 18, 2015 (80 FR
72077), and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Cancer Institute
(NCI), National Institutes of Health, may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
For Further Information Contact: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Janet S. de Moor, Ph.D., MPH,
Project Officer, Division of Cancer
Control and Population Sciences, 9609
Medical Center Drive, 3E438, MSC
9764, Rockville, MD, 20850 or call nontoll-free number 240–276–6806 or Email
your request, including your address to:
janet.demoor@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Proposed Collection: The National
Physician Survey of Precision Medicine
in Cancer Treatment 0925–NEW,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of this study is
to investigate the current practice of
precision medicine in cancer treatment
among medical oncologists in the U.S.
This is a nationally representative
survey designed to assess oncologists’
current and potential use of genomic
testing, to inform the development of
interventions to facilitate optimal use of
genomic testing and to improve patientphysician discussions of the risks,
possible benefits, and uncertainties
surrounding the use of these tests.
Current knowledge of this topic is
limited as there are no nationallyrepresentative studies on this topic to
date. There are only two non-federal
studies two that have examined
physicians’ knowledge and attitudes
regarding somatic genetic and genomic
testing. The survey will be administered
by mail and web to medical oncology
physicians across the U.S. Nonrespondents will be invited to complete
a follow-back survey to share their
reasons for not participating. The study
findings will inform NCI of relevant
issues and concerns relating to the
application of precision medicine to
current and future cancer treatment
patterns and practice. This information
will also inform the development of
new funding initiatives to optimize the
use of precision medicine in cancer
treatment. Additionally, information
collected as part of this survey will be
used to develop physician educational
materials to address barriers to precision
medicine in cancer care delivery.
OMB approval is requested for 2
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
350.
mstockstill on DSK4VPTVN1PROD with NOTICES
TOTAL ANNUALIZED BURDEN HOURS
Form name
Type of
respondent
Telephone Screener .......................................
Precision Medicine Survey—Pilot Study ........
Precision Medicine Survey—Full Study ..........
Non-response Follow-back Survey .................
Receptionists ......................
Oncology Physicians ..........
Oncology Physicians ..........
Oncology Physicians ..........
VerDate Sep<11>2014
20:41 Feb 25, 2016
Jkt 238001
PO 00000
Frm 00066
Fmt 4703
Number of
respondents
Sfmt 4703
Number of
responses per
respondent
775
175
600
40
E:\FR\FM\26FEN1.SGM
1
1
1
1
26FEN1
Average
burden per
response
(in hours)
3/60
20/60
20/60
5/60
Total annual
burden hour
39
58
200
3
]]>Agencies
[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Notices]
[Pages 9867-9869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Draft National Toxicology Program Monograph on Immunotoxicity
Associated With Exposure to Perfluorooctanoic Acid or Perfluorooctane
Sulfonate; Availability of Document; Request for Comments; Notice of
Meeting
SUMMARY: The notice announces a meeting to peer review the draft NTP
monograph on immunotoxicity associated with exposure to
perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS). The
Office of Health Assessment and Translation, Division of the National
Toxicology Program (DNTP), National Institute of Environmental Health
Sciences (NIEHS), prepared the draft NTP monograph. The peer review
meeting is open to the public. Registration is requested for both
public attendance and oral comment and required to access the webcast.
Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/36639.
DATES: Meeting: July 19, 2016, 9:00 a.m. to approximately 2:00 p.m.
Eastern Daylight Time (EDT).
Document Availability: The draft NTP monograph should be available
by June
[[Page 9868]]
7, 2016, at https://ntp.niehs.nih.gov/go/36639.
Written Public Comment Submission: Deadline is July 5, 2016.
Registration for Oral Comments: Deadline is July 12, 2016.
Registration for Meeting and/or to View Webcast: Deadline is July
19, 2016. Registration to view the meeting via the webcast is required.
ADDRESSES: Meeting Location: Rodbell Auditorium, Rall Building, NIEHS,
111 T.W. Alexander Drive, Research Triangle Park, NC 27709.
Meeting Web page: The draft NTP monograph, preliminary agenda,
registration, and other meeting materials will be available at https://ntp.niehs.nih.gov/go/36639.
Webcast: The URL for viewing webcast will be provided to those who
register.
FOR FURTHER INFORMATION CONTACT: Dr. Yun Xie, NTP Designated Federal
Official, Office of Liaison, Policy, and Review, DNTP, NIEHS, P.O. Box
12233, MD K2-03, Research Triangle Park, NC 27709. Phone: (919) 541-
3436, Fax: (301) 451-5455, Email: yun.xie@nih.gov. Hand Delivery/
Courier: 530 Davis Drive, Room 2161, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background on PFOA and PFOS: PFOA and PFOS are persistent chemicals
that are widely distributed in the environment, in part because of high
stability and little to no expected degradation in the environment.
PFOA and PFOS have been used extensively over the last 50 years in
commercial and industrial applications, including food packaging,
lubricants, water-resistant coatings, and fire-retarding foams. Through
voluntary agreements, the primary manufacturer of PFOS phased out
production in 2002, and PFOS is no longer manufactured in the United
States. Similar arrangements have been made for PFOA, and eight
companies that manufacture PFOA committed to eliminate emissions and
product content by 2015. Although emissions have been dramatically
reduced, the persistence and bioaccumulation of both PFOA and PFOS
result in detectable levels in the U.S. population and, therefore,
these chemicals are of potential human health relevance. Several recent
publications from 2012-2014 have linked PFOA and PFOS exposure to
functional immune changes in humans, which are consistent with evidence
of PFOA- and PFOS-related immunotoxicity in animal studies.
NTP has conducted a systematic review of the evidence for an
association between exposure to PFOA or PFOS and immunotoxicity or
immune-related health effects. The NTP evaluation concept for
immunotoxicity associated with exposure to PFOA or PFOS was presented
and discussed at the NTP Board of Scientific Counselors (BSC) meeting
on December 10, 2014 (79 FR 62640). The NTP evaluation concept, related
presentation, and BSC meeting minutes are available at https://ntp.niehs.nih.gov/go/9741. The protocol for conducting this systematic
review is available at https://ntp.niehs.nih.gov/go/749926.
Meeting and Registration: The meeting is open to the public with
time set aside for oral public comment. Please note that this will be
both an in-person and web-based meeting. The chair of the peer review
panel and NTP staff will be at the meeting location at NIEHS. The peer
review panel members will be attending the meeting via web-based video
conferencing. Public attendees are welcome to watch the meeting via
webcast or attend in person. Attendance at NIEHS is limited only by the
space available.
Registration to attend the meeting in-person or to view the webcast
is by July 19, 2016, at https://ntp.niehs.nih.gov/go/36639. Registration
is required to view the webcast; the URL for the webcast will be
provided in the email confirming registration. Visitor and security
information for those attending in-person is available at https://www.niehs.nih.gov/about/visiting/index.cfm. Individuals with
disabilities who need accommodation to participate in this event should
contact Dr. Yun Xie at phone: (919) 541-3436 or email: yun.xie@nih.gov.
TTY users should contact the Federal TTY Relay Service at (800) 877-
8339. Requests should be made at least five business days in advance of
the event.
The preliminary agenda and draft NTP monograph should be posted on
the NTP Web site (https://ntp.niehs.nih.gov/go/36639) by June 7, 2016.
Additional information will be posted when available or may be
requested in hardcopy, see FOR FURTHER INFORMATION CONTACT. Following
the meeting, a report of the peer review will be prepared and made
available on the NTP Web site. Individuals are encouraged to access the
meeting Web page to stay abreast of the most current information
regarding the meeting.
Request for Comments: The NTP invites written and oral public
comments on the draft NTP monograph. The deadline for submission of
written comments is July 5, 2016, to enable review by the peer review
panel and NTP staff prior to the meeting. Registration to provide oral
comments is by July 12, 2016, at https://ntp.niehs.nih.gov/go/36639.
Public comments and any other correspondence on the draft NTP monograph
should be sent to the FOR FURTHER INFORMATION CONTACT. Persons
submitting written comments should include their name, affiliation,
mailing address, phone, email, and sponsoring organization (if any)
with the document. Written comments received in response to this notice
will be posted on the NTP Web site according to NTP's guidelines for
public comments (https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf), and the submitter will be
identified by name, affiliation, and/or sponsoring organization if
applicable.
Public comment at this meeting is welcome, with time set aside for
the presentation of oral comments on the draft NTP monograph. Guidance
for oral public comments is available at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf. In addition to in-person
oral comments at NIEHS, public comments can be presented by
teleconference line. There will be 50 lines for this call; availability
is on a first-come, first-served basis. The lines will be open from
9:00 a.m. until approximately 2:00 p.m. EDT on July 19, 2016, although
oral comments will be received only during the formal public comment
periods indicated on the preliminary agenda. The access number for the
teleconference line will be provided to registrants by email prior to
the meeting. Each organization is allowed one time slot. At least 7
minutes will be allotted to each time slot, and if time permits, may be
extended to 10 minutes at the discretion of the chair.
Persons wishing to make an oral presentation are asked to register
online at https://ntp.niehs.nih.gov/go/36639 by July 12, 2016, and
indicate whether they will present comments in-person or via the
teleconference line. If possible, oral public commenters should send a
copy of their slides and/or statement or talking points at that time.
Written statements can supplement and may expand the oral presentation.
Registration for in-person oral comments will also be available at the
meeting, although time allowed for presentation by on-site registrants
may be less than that for registered speakers and will be determined by
the number of speakers who register on-site.
Background Information on OHAT: OHAT was established to serve as an
environmental health resource to the public and regulatory and health
agencies (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094430). This
office conducts evaluations to assess the
[[Page 9869]]
evidence that environmental chemicals, physical substances, or mixtures
(collectively referred to as ``substances'') cause adverse health
effects and provides opinions on whether these substances may be of
concern given what is known about current human exposure levels. OHAT
also organizes workshops or state-of-the-science evaluations to address
issues of importance in environmental health sciences. Information
about OHAT is found at https://ntp.niehs.nih.gov/go/ohat.
Background Information on NTP Peer Review Panels: NTP panels are
technical, scientific advisory bodies established on an ``as needed''
basis to provide independent scientific peer review and advise the NTP
on agents of public health concern, new/revised toxicological test
methods, or other issues. These panels help ensure transparent,
unbiased, and scientifically rigorous input to the program for its use
in making credible decisions about human hazard, setting research and
testing priorities, and providing information to regulatory agencies
about alternative methods for toxicity screening. The NTP welcomes
nominations of scientific experts for upcoming panels. Scientists
interested in serving on an NTP panel should provide current curriculum
vitae to the FOR FURTHER INFORMATION CONTACT. The authority for NTP
panels is provided by 42 U.S.C. 217a; section 222 of the Public Health
Service (PHS) Act, as amended. The panel is governed by the Federal
Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of advisory committees.
Dated: February 22, 2016.
John R. Bucher,
Associate Director, NTP.
[FR Doc. 2016-04102 Filed 2-25-16; 8:45 am]
BILLING CODE 4140-01-P
